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Abstract 
 
 
 Stems cells have shown decisive applications in recent times helping to alleviate human 
suffering.  Several sources exist for stem cells, some having great ethical concerns while others 
face clinical obstacles. The application of stem cell technology in society is based on ongoing 
research initiatives. Several ailments of the human body facing large barriers to heal are now 
having those walls broken down at dramatic rates. Yet despite the ground covered within a short 
time, groups around the world still undermine the findings.  Rigid doctrines and teachings guide 
the cultivation and application of stem cells, with embryonic stem cells facing harsh criticism 
from major religious institutions. Actions are being sought within several communities to 
maximize the succession of this novel technology by creating leading research foundations for 
the world to follow. In many countries, international stem cell efforts are expanding the ability to 
care for individuals around the world and continuing to provide strong societal benefits, giving 
the dissenters shaky ground to stand on. 
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Project Objective 
 
 By defining key points in the stem cell debate and educating readers on the types of stem 
cells and how they are classified, this project aims to inform readers why this field will have 
profound impact on society and the future of civilization. Modern technology proliferates 
quickly while often forgetting to inform society of the beneficial goals reached.  Applications of 
stem cell technology have progressed to human clinical trials with success being achieved in 
several cases. The impact of such applications must be made known clearly to maintain an 
educated society.  The five major world religions agree that working with adult stem cells should 
be encouraged, but disagree on the use of embryos.  The technologies present today within 
regenerative science are found as obligatory endeavors in some religious communities. 
Informing readers of the stances held by each major religion will help guide the general 
perspective currently fractured between rhetoric and objective analysis. Through educating the 
reader, future legislative acts will become clearer in intention and the voice of communities can 
soundly help contribute to the direction regenerative science is heading.  With the project’s last 
words an expression on the future state of regenerative science is offered by the author. 
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Chapter-1:  Stem Cell Types and Sources 
 
Stem cells exist as long living cells within a body and are capable of differentiating into 
many specialized tissue types. These cells help govern tissue growth, repair damaged tissue, and 
can even assist in cancer cures (ISSCR, 2011).  One stem cell can give rise to many cells through 
self-renewal, and during this self-renewal process a stem cell can differentiate giving rise to a 
similar stem cell and one specialized cell. These specialized cells, in large quantities, make up 
the backbone of tissues and organs (ISSCR, 2011).  Due to the flexibility in forming new tissues, 
stem cells are the basis of the field of regenerative medicine, offering many potential benefits to 
sufferers within a society.  However, some types of stem cells are ethically controversial. The 
purpose of this chapter is to highlight the many types of stem cells and illuminate how they are 
created and traced.  
 
Stem Cell Classification 
Stem cells are of many types, each encompassing different paths of specialization. 
Totipotent stem cells can differentiate into any subclass of cell, including any cell in the adult 
body or any extra-embryonic tissue such as the placenta.  In mammals, the only cells recognized 
to do this are the initially fertilized ovum and descendant cells until the 8-cell stage (Chamany, 
2004).  After about 5 days post-fertilization, the embryo forms a blastocyst or hollow ball of 
cells.  Cells located in the inner cell mass of the blastula are pluripotent embryonic stem cells. 
These cells are are able to differentiate into any cell in the adult body via the three primary germ 
layers, yet are unable to produce the placenta (Chamany, 2004).  In addition, normal adult cells 
can be induced or modified into acting as pluripotent stem cells by reprogramming via viruses to 
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insert genetic changes into the cells, and this has further paved the way for ethical procedures in 
modern regenerative medicine (ISSCR, 2011).  Multi-potent stem cells act as foundational cells 
within a variety of tissues and can differentiate into several types of related tissues.  Examples of 
multi-potent stem cells are mesenchymal stem cells and hematopoietic stem cells.  Uni-potent 
stem cells have only a single potential path of differentiation, and are the most specialized type 
of cells in the body (Chamany, 2004). 
 
Stem Cell Identification 
Embryonic stem cells are identified as the inner cell mass of the blastocyst. Adult stem 
cells are far more difficult to identify.  ASCs are found in low numbers throughout adult tissues, 
so scientists attempt to identify them using specific marker proteins located on the cell surface 
(Schultz et al., 2004).  Markers of pluripotency include Oct-4, SSEA-3, SSEA-4, TRA 1-60, 
TRA 1-81 and alkaline phosphatase (Klimanskaya et al., 2005).  Embryonic stem cells derived 
from a blastocyst carry these markers, and are tested in each stage of expansion to ensure their 
pluripotency.  A widely used surface marker for bone marrow stem cells is CD34+, a 115 
kilodalton glycoprotein expressed in 1.5% of normal bone marrow cells (Schultz et al., 2004).  
Adult epithelial stem cells display one common marker throughout this lineage, the Lgr6 marker 
(Snippert et al., 2010).  This marker was traced during wound repair, and each newly formed 
layer of epithelial cell structures showed Lgr6 presence (Snippert et al., 2010).  
 
Embryonic Stem Cells 
 Embryonic stem cells are derived from the inner cell mass of 5-day old embryos.  The 
embryos are obtained from in-vitro fertilization (IVF) clinics intended for reproductive purposes.  
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In the United States, a ban exists for creating embryos solely for research purposes; only excess 
IVF embryos may be obtained from reproductive clinics with donor consent.  Once the family 
has enough children, the excess embryos are usually discarded.  Legislation from the 1970’s 
allowed these excess embryos to be used in research with donor consent (Klimanskaya et al., 
2006).  
Embryonic stem cells were first isolated from mice in 1981 (Martin, 1981), and from 
humans in 1998 (Thomson et al., 1998).  For the human cell extraction, the cells were grown on 
a feeder layer of irradiated mouse fibroblast cells to provide a scaffold and growth factors and 
are then grown into a stem cell line (Chamany, 2004).  The initial use of animal cells as a feeder 
layer was eventually replaced by a human feeder layer due to worries about animal viruses or 
contamination with animal proteins. Both were health issues with cells that would be implanted 
into human patients.  The removal of the stem cells from the embryo usually destroys the 
embryo, which some individuals argue is murder leaving these cells as an ethically controversial 
topic.  Following their isolation, embryonic stem cells cannot be used to create an entirely new 
organism (Chamany, 2004), but can be grown and differentiated into any type of tissue in the 
adult organism, with direct clinical applications.  
  
Adult Stem Cells 
Adult stem cells are a very broad category that includes any type of stem cell not derived 
from an embryo.  Generally, these cells are harder to isolate than embryonic stem cells and are 
harder to grow; due to these obstacles many scientists prefer working with ES cells if possible 
when trying to treat a disease.  Adult stem cells do have some clinical applications, although  
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limited.  Examples of adult stem cells are hematopoietic stem cells, cardiac stem cells and neural 
stem cells. 
 
Hematopoietic Stem Cells 
Hematopoietic stem cells are multi-potent and traditionally derived from the bone 
marrow.  These are the best characterized type of stem cell, and have been used for decades in 
bone marrow transplants to treat various blood cancers (reviewed in Bortin et al., 1994).  
Hematopoietic stem cells usually differentiate into all types of blood cells (red blood cells, white 
blood cells, platelets, etc.), but recent evidence indicates they may be able to form tissues other 
than blood, so they may be more potent than originally thought (Dorshkind, 2002). 
  
Cardiac Stem Cells 
 Scientists originally thought that heart muscle lacked the ability to regenerate following 
damage, but experimental research verified that cardiac tissue can regenerate from adult cardiac 
stem cells.  These stem cells were first isolated in 2003 (Beltrami et al., 2003) and were thought 
to have the cell surface marker c-kit.  However, other scientists argued these cells may actually 
represent hematopoietic stem cells that migrated to the heart, and that Isl1+ cells actually 
represent true cardiac stem cells (Laugwitz et al., 2005).  Stem cells found in the heart occur in 
clusters in the atrial and ventricle walls, interspersed between the muscle cells (Touchette, 2004), 
and have been found both in rats and humans.   
Experiments in vivo and in vitro on Fisher rat myocardial sections showed stem cell 
differentiation from a primitive stem cell expressing Ki67 surface marker that differentiated 
solely to a cardiac myogenic lineage (Beltrami et al., 2003).  The marker c-kit
POS
 was also 
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present, which normally represents hematopoietic stem cells, but the Ki67 cells appeared to have 
lost their ability to form blood cell lineages.  When the isolated c-kit
POS
 cells were plated into 
enriched F12K medium, the cells maintained stable phenotypes and remained undifferentiated.  
Growth tests indicated that the cells expressed clonogenicity, had self-renewal properties, and 
were pluripotent (Beltrami et al., 2003).  Further tests on the structure and function of the cells 
determined that they were capable of contraction.  Experimental evidence revealed that cardiac 
tissue in normal and diseased mammalian hearts appears to have self-renewal capabilities. While 
the vast majority of cardiac cells are terminally differentiated into cardiac muscle, a small group 
of stem cells helps maintain the tissue (Beltrami et al., 2003; Philipkoski, 2003). 
 
Neural Stem Cells 
  Neural cells age and decay over time and until recently nerve tissue was thought to be 
incapable of regeneration.  We now know that the brain contains two narrow regions that support 
regeneration, the sub-ventricular and sub-granular zones, which appear to contain neural stem 
cells.  Neural stem cells were first isolated in 1989 (Temple, 1989), and appear to participate in 
the formation of all three main types of brain cells: neurons, astrocytes and oligo-dendrites.  
Early hypotheses limited these stem cell abilities to only participating in scar formation after 
injury, indicating limited neurogenesis (Bjorklund & Lindvall, 2000), but we now know they are 
multipotent.  
Early experiments tested the existence of stem cells within the brain by inducing lesions 
within mouse brains. Less than 2% of newly formed cells expressed neural markers, and the rest 
were scar tissue unable to link with neural circuitry.  However, the expression of the neural stem 
cell markers in even a limited number of cells was enough to stimulate further research 
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(Bjorklund & Lindvall, 2000). 
 Embryonic stem cells can also be differentiated into neural cells (Huettner, 2006). The 
cells are capable of sodium, potassium and calcium channels gated by neurotransmitters. While 
the number of neurotransmitter receptors is limited, they are able to make basic communication 
through synaptic contacts. The cells polarized phenotype resembles neurons from the central 
nervous system (Huettner, 2006).  
 
Epithelial Stem Cells 
 Epithelial stem cells have also been discovered in skin and other organ surface tissues, 
and are responsible for the regenerative properties of the epithelial layers.  One type of epithelial 
stem cell in mouse colon epithelium appears to have the surface marker Lgr5 (Barker et al., 
2007).  In mice, the crypt base columnar cells of the intestine express Lgr5, while the villi do not.  
Lgr5 may be responsible for rapid stem cell growth due to the high volume of cell turnover 
within the intestines.  For mice, this turnover is every three to five days (Barker et al., 2007).  
The Ki67 proliferation marker is also found within the columnar cells.  Using fluorescent 
microscopy, the Ki67 cells were found to form three dimensional wedge shapes (Barker et al., 
2007).  However, the Lgr5 cells appear to be the dominant stem cells.  Within hair follicles, there 
is also a small amount of Lgr5 expression (Barker et al., 2007).  
 
iPS Cells 
 One key issue during cell therapy is the potential rejection of the transplanted cells by the 
patient’s immune system.  Thus, scientists are seeking ways of deriving stem cells from a patient 
that would be genetically identical to the patient’s cells.  In recent years, adult skin cells have 
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been reprogrammed into pluripotent-like stem cells using viruses to carry new genes into the 
cells.  These cells are defined as induced pluripotent stem cells, and have become one of the 
more prominent topics in the regenerative research field.  In theory, induced cells could provide 
pluripotent stem cells for therapy that are genetically identical to a patient and do not require an 
embryo. 
Induced pluripotent stem cells were first derived from mice in 2006 (Takahashi et al., 
2006) and from humans in 2007 (Takahashi et al., 2007).  The initial reprogramming involved 
delivering four genes into adult skin cells: Oct3/4, Sox2, c-Myc and Klf4. The genetic sequences 
caused a reversion, or a de-differentiation effect, to pluripotent states similar to embryonic stem 
cells (Baker, 2007).  However, implantation of the cells sometimes caused tumors, so researchers 
eventually omitted the myc oncogene component of the mixture, and were still able to derive 
pluripotent cells (Baker, 2007; Hayden & Baker, 2009).  Later improvements eliminated the use 
of the viruses to deliver the reprogramming genes.  
One problem with induced pluripotent cells is some scientists report the cells have DNA 
mutations and an abnormal numbers of chromosomes relative to pre-induction (Pera, 2011).  
Some scientists argue the mutations might result from the use of virus delivery during the cell 
programming. DNA variations are not usually observed in normal embryonic stem cell lines.  
The mutations in the reprogrammed cells can cause cancer when they involve cell cycle 
regulation or growth factors (Pera, 2011).  Mutated induced pluripotent stem cells that differ 
significantly in gene expression from embryonic stem cells cannot be used for clinical 
applications.  A powerful alternative to retroviral gene infection is a system that completely 
eliminates the viral delivery system from the equation.  Direct insertion of the reprogramming 
proteins through the cell wall can be accomplished by attaching the proteins to polyarginine 
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which carries the proteins through the cell membranes (Aldhous, 2009).  Using mouse fibroblast 
cells soaked in polyarginine-tagged proteins for 12 hours four times over two weeks, stem cell 
colonies formed.  No genetic markers for cancer were apparent in experiments, and the 
efficiency of induction was higher than that of adenovirus infection, although much less than 
retrovirus induction (Aldhous, 2009).  
One key remaining question for these induced stem cells is whether they are truly 
pluripotent.  Although some experiments have shown that induced pluripotent stem cells can 
form multiple tissues, other more recent experiments indicate these cells may harbor mutations 
that hinder their differentiation potential.  More experiments are required to determine their true 
potency.  Some experiments have indicated differentiation into neurons.  Fibroblasts treated with 
five factors: Brn2, Brn4, Myt1l, Zic1 and Olig2, allowed embryonic stem cells to form. 
Continued experiments on these cells led to neuron like cells differentiation that made 
connections and synapses (Vierbuchen et al., 2010). Five days were required for the branching 
neural cells, giving rise to a quick and efficient system of forming a neural network.  Other work 
indicated iPS cells may be pluripotent (Yu et al., 2007).  Yet induced cells still require more 
work until they can be used in the clinic, as they may contain numerous mutations that lead to 
cancer or cause immune rejection.  Their promise is they could be used without regard to ethical 
or moral obligations, unlike embryonic stem cells that require the destruction of the embryo (Yu 
et al., 2007). 
   
Parthenote ES Cells 
 Parthenotes, unfertilized eggs grown into embryos, yield some promise for stem cell 
culture.  Parthenogenesis is a type of asexual reproduction in which the female egg begins 
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dividing without fertilization.  The process occurs naturally in some insects, but not in mammals.  
The mammalian eggs can be artificially stimulated to begin dividing while restraining 
chromosomal ejection to maintain the normal number of chromosomes.  If the mammalian 
parthenote can be grown to the blastocyst stage, embryonic stem cell lines can be derived 
(Holden, 2002). Because mammalian parthenote embryos cannot develop into a child, some 
scientists believe these embryos have lower moral status than a fertilized embryo, so perhaps 
these cells could replace traditional embryo-derived stem cells. Parthenote systems might work 
to derive cells genetically identical to a female egg donor, but males are left without such a 
system (Holden, 2002).  Parthenote stem cells have been derived for monkeys (Mitalipov et al., 
2001) but not yet reliably in humans. 
 
Chapter-1 Conclusions 
 Stem cells are not all alike.  Although early work used bone marrow derived stem cells to 
treat various blood cancers, later experiments have shown that stem cells exist in almost all adult 
tissues that help function in tissue maintenance and repair.  Research has helped identify cell 
surface markers specific to different types of stem cells, to aid their isolation.  Regeneration of 
tissue within the body is natural, and the discovery of stem cells within adult tissues helped 
define the causes of the regeneration.  Stem cells do not just exist within the embryo, but within 
the bone marrow, the bone, the muscle, even organs once thought to be non-regenerating. If 
these cells are so prolific within the body, then hopefully there is there a way to harness that 
regenerative capacity to heal even the most destructive wounds. 
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Chapter-2:  Stem Cell Applications 
 
 Regenerative medicine is a new field of science derived from the manipulation of stem 
cells.  Introducing stem cells into damaged tissues with the appropriate potency, the tissue can 
sometimes become repaired.  Using cell therapy diseases previously thought to be uncurable may 
be treatable.  The purpose of this chapter is to go beyond earlier discussion of the various types 
of stem cells to describe how they are being used to treat diseases. Three categories of disease 
are discussed: spinal cord injury, neurodegenerative diseases and heart disease. 
 
Stem Cell Treatment of Spinal Cord Injuries 
Scientists are researching the use of stem cells to treat individuals with spinal cord injury.  
In one experiment, mouse paralysis was induced by using Neuro-adapted Sinbis Virus which 
targeted motor neurons leading to a permanent paralysis (Kerr et al., 2003).  Transplantation of 
300,000 stem cells into the spinal fluid caused a migration of the stem cells and adherence to the 
meninges within the spinal cord (Kerr et al., 2003), allowing the mice to survive for more than 
one month.  Blind studies on the behavior of three groups of rodents after implantation of stem 
cells, baby hamster kidney cells, or human fibroblast cells individually for each group showed 
significant recovery of the stem cell group three months later (Kerr et al., 2003). Hind limb 
paralysis decreased significantly, allowing the rats the move upright once again. The stem cells 
created axonal growth and also allowed motor neurons to make significant connections. 
 Partial spinal cord injuries in rats that impaired walking were treated using oligo 
dendrites differentiated from human embryonic stem cells.  Migration of the stem cells occurred, 
and the cells eventually relocated to appropriate neural sites within the spinal cord.  Seven days 
after treatment, myelin tissue formed around the damaged neurons, and within two months the 
18 
 
rats showed increased motor control while the control rats showed no difference (UCI, 2005).  
Motor neuron damage appears to be repairable in rats, giving hope for regeneration in humans. 
During 2009, human clinical trials for stem cell implantation into spinal cords were approved by 
the Food and Drug Administration (NY Times, 2009).  
 
Stem Cell Treatment of Neurodegenerative Diseases and Stroke 
 Neurodegenerative diseases are becoming increasingly prevalent in our ageing society.  
These diseases include Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral 
sclerosis. Scientists are researching the use of stem cells, both embryonic and adult, in re-
growing areas of the brain affected by these diseases.  Mouse embryonic stem cells have been 
cultured into CNS neurons and motor neurons, allowing the complex circuitry of the nervous 
system to rebuild from damage. The new cells can form synapses, connect with muscles, extend 
axons, and most importantly can function (Wichterle et al., 2002).  Human embryonic stem cells 
have also been differentiated into cells expressing neural markers.    
Parkinson’s disease is a neurodegenerative disorder in which the substantia nigra area of 
the brain is destroyed, decreasing the production of dopamine in the brain.  Human embryonic 
stem cells have been shown to be capable of differentiating into neural cells expressing 
dopamine, leaving hope to utilize their effects in treating this disease (Perrier et al., 2004).  Over 
one third of the new cells had synaptic contacts.  Clinical use of embryonic stem cells for 
Parkinson’s requires the use of immune-suppressants to prevent rejection of the implanted cells, 
unless the implanted cells are induced stem cells derived from the patient. 
Human clinical trials have shown a reversal of adult Parkinson’s disease through the use 
of neural stem cell transplantation (Ertelt, 2009).  Nearly 80% of motor function improved 
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through a 36 month period (Ertelt, 2009).  In this experiment, the patient’s own adult neural stem 
cells were used, which bypassed ethical issues, and the patient did not need an 
immunosuppressant. No rejection of the cells occurred. Only half of the patient’s brain was 
treated, yet several years later no symptoms of the disease were visible.  
In animal trials, the survival rate of post-treatment for Parkinson’s is limited. 
Neuroprotective chemicals are lower than normal in Parkinsonian animals, so a possible path to 
correcting this deficiency is to engineer stem cells expressing these molecules (Lindvall & 
Kokaia, 2006).  Possible long term therapies for humans might also require the expression of key 
neuroprotective molecules. 
 Rat trials determined the behavior of an untreated Parkinsonian rat, turning constantly 
and moving only in a linear path. The behavior of the rats was changed with stem cell treatment 
(Ryan, 2004).  Transplanting human stem cells into the brains led to a significant reduction of 
these behaviors. The stem cells implanted in the brain and differentiated into dopamine 
producing neurons.  In this particular case, the implanted cells failed to propagate, perhaps due to 
the presence of animal viruses (Ryan, 2004). 
Stroke has also been treated with stem cells.  Stroke induced in rodents has been treated 
with the use of adult bone marrow stem cells for neural regeneration (Lindvall and Kokaia, 
2004).  Experimental data showed frontal lobe regeneration with significant gains to normal 
behavior. The dead neurons from the stroke initially led to interrupted neural circuitry. Over time 
this circuitry was restored through neurogenesis. The regenerated neurons expressed 
neurotransmitters and are able to release dopamine (Lindvall and Kokaia, 2004).  In this 
experiment, the cells were delivered by direct implantation to the affected locations, allowing 
cell migration to fill in the damaged cortex.  Other delivery methods might use micro-scaffolding 
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layered onto the damaged brain, allowing stem cells to grow within a pre-designed structure 
(Science Daily, 2008). Derivations of the micro-scaffolding might include feeder particles laced 
into the scaffold for a more efficient cell growth, and structural formations to ensure a higher cell 
survival rate.  Rat models utilizing micro-scaffold technology have used various scaffold 
materials, allowing specific differentiation depending on where the scaffold was applied (UPI, 
2007).  
 A single human clinical trial using adult bone marrow stem cells was conducted for 
neural regeneration of a stroke victim (Vega, 2006).  Before treatment, the stroke damage left the 
patient crippled, but less than two months after treatment the patient was able to fully navigate 
city subways once again.  Bone marrow stem cell applications for healing neural damage shows 
great diversity of stem cell potential, given that their normal mode of differentiation is not neural 
in type.  Human bone marrow stem cells migrate from their applied location into the brain and 
begin differentiating into astrocytes (Mezey et al., 2000).  The application of bone marrow stem 
cells could allow mass production of missing neural or motor cells within individuals. Utilizing 
the patient’s own bone marrow bypasses immune-rejection concerns and would negate possible 
tumorous growth from embryonic stem cells (Mezey et al., 2000).  
  
Stem Cell Treatment of Heart Disease 
 Heart attacks are one of the leading causes of mortality in North America.  Initial damage 
to the myocardial tissue leads to future heart failure, due to the increased demand on the 
remaining tissue (Couzin, 2006). German scientists initially developed a technique to use bone 
marrow stem cells to differentiate into heart muscle, although an early clinical trial failed.  
Affected arteries were injected with bone marrow stem cells in two groups, patients who had 
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recent heart attacks and those who had an attack six years prior.  The treatment was found to be 
safe, but no significant difference was found between the placebos groups contrasted with the 
experimental group (Couzin, 2006).  
 Later experiments began showing regenerative progress.  Following heart attacks, 
mononuclear bone marrow stem cells were infused into the left ventricle.  The patients showed 
quick gains on systolic and diastolic homeostasis (Plewka et al., 2009).  While pre-treatment 
patients showed significant ventricular dysfunction, after treatment the treated group showed 
significant improvement on the health of the ventricle.  Cell necrosis, residual ischemia, 
microvascular dysfunction, and wall motion abnormalities were also significantly reduced in the 
treatment group (Plewka et al., 2009).  Although myocardial tissue regeneration in clinical trials 
still has some time before long term effects are documented, recent research has shown that in 
the short term the gains significantly reduce mortality in populations with high heart attacks. 
 Embryonic stem cells, cardiac stem cells, myoblasts, or adult bone marrow stem cells 
have all been shown to differentiate into myocardial unipotent cells. Intravenous injections of the 
stem cells directly into damaged tissue is the general method of cell delivery (NIH, 2006). The 
cells tend to migrate much like tumor cells do.  Tracking their movement in-vivo is difficult, but 
microscopy reveals that the efficiency of cell delivery and survival is near 10%.  Stress, 
inflammation, and hypoxia generally causes a large amount of injected cells to die (NIH, 2006). 
Bone marrow stem cells used on rat heart models have been shown to regenerate 
cardiomyocytes, vascular endothelium, and smooth muscle cells (NIH, 2006).  Resident cardiac 
stem cells, endothelial progenitor cells, and umbilical cord blood cells also show similar promise 
for treating cardiac damage. 
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Chapter-2 Conclusions 
 Stem cell applications to regenerate lost cellular populations may allow the treatment of 
previously uncurable diseases.  Long term implications of stem cell regenerative techniques will 
become increasing important in an ageing population, while helping reduce healthcare costs and 
reduce disabilities and mortalities. Ageing populations currently encountering degenerative brain 
diseases, heart attacks, or other burdening diseases might retain their role in society instead of 
retiring due to health concerns. Military injuries and mortalities might be reduced through bone 
marrow transplants to regenerate traumatic injuries. Heart attack patients might find the 
regenerative properties of stem cells healing their muscle tissue and reducing the cost of their 
disease.  In general, the use of stem cell therapy in society might affect the vast majority of 
citizens, allowing a refocus of medical efforts on preventive care instead of costly long term 
rehabilitative care. 
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Chapter-3:  Stem Cell Ethics 
 
 Manipulation of the fertilized human ovum for research purposes is generally met with 
ethical arguments. These arguments range from whether the blastocyst is considered a living 
human, and if so at which point these cells become human? Whether destroying the embryo to 
obtain embryonic stem cells is disrespectful towards god, and whether society can use the cells 
of the blastocyst for regenerative applications. Many of these questions are rooted in religious 
ideology whereas few are rooted in natural evolution moralities. The majority of arguments are 
centered about embryonic stem cell research and the religious implications even though such 
research is only a small facet of regenerative stem cell science. 
 
Buddhism and Hinduism 
 Hindu perspectives on embryos depart from the general major religious grounds.  
Generally to Hindus, life is sacred and is not to be destroyed.  A paradox is developed within this 
perspective which was resolved by ancient Rishis: only the highest conscious being shall be 
ensured protection. Based on this understanding a higher conscious life form can devour a lower 
level life form to ensure survival, such as humans eating plants and animals (Bahnot, 2008). The 
primordial life forms of embryos, under the premise of Rishis understanding, can then be used to 
propagate current and future human life. Hindu doctrines state that all life is evolving towards 
god, and in our current life we are only in a small phase of that movement.  Sacrificing lower 
level conscious cells for the highest conscious, or human life, is only but a step towards that 
evolution (Bahnot, 2008). 
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 Buddhist ideology supports medical research similarly to Islamic and Jewish ideologies. 
Buddhism has historical roots in the spread of the teaching of medical traditions passed through 
Asia (Hughes & Damien, 1995).  The relationship between Buddhist teachings and medical 
practice has little documentation, indicating a slight subjection towards how medicine is 
conducted.  Personhood is considered by a Buddhist as one who is aware of the difference 
between self and other, conscious of life, and has the ability to conduct purposive behaviors 
(Hughes & Damien, 1995). Buddhist teachings parallel traditional Hindu teachings in that 
consciousness begins with conception. Excess embryos at in-vitro fertilization clinics which have 
been fertilized by the father’s sperm are seen as conscious life forms under Buddhist ideology. 
The issue becomes one of karmic holding, where killing smaller life forms generates less 
negative karma compared to killing late term fetuses or adults (Hughes & Damien, 1995). 
Moreover, negative karma can be counteracted with positive acts; following the destruction of 
the embryo and mending the body with regenerative medicine can incur such positive karma.  
Stem cell research is seen as a balanced karmic pursuit and is within the confines of positive 
behaviors Buddhist teachings accept.  
 
Catholicism 
 On August 9
th
, 2001, President Bush designated limited funding for embryonic stem cell 
research (ACO, 2006), allowing federal funding for research performed on previously derived 
embryonic stem cell lines, but not to derive new cell lines. The policy was enacted in response to 
the U.S. Catholic Church pleading for President Bush to stop the manipulation and destruction of 
human lives. Not allowing federal money to be spent deriving new cell lines meant capping the 
potential of fetal destruction.  Since the embryos used to derive the previously existing cell lines 
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were already destroyed no further harm would come from allowing federal funding for those 
cells.  The lives being destroyed (as defined by the church) were embryonic stem cell lines 
already committed to research and had no potential for growth into a human. The ethical 
argument pushed forth by the Catholic Church is not the use of regenerative medicine, but 
instead the argument of when live originates. If another source of stem cells is used then the 
debate on whether embryos are relevant to regenerative medicine ends. 
 Distribution of pamphlets criticizing the use of embryonic stem cell research spread 
across the United States in attempts to educate readers about the religious moral hazards of such 
research.  These documents create a cleft between religious ideologies and the scientific 
community. The pamphlet did not attempt educating the reader on both sides of the issue, instead 
only focuses on limited facets of how the research is conducted.  A short discussion of the impact 
on human health is included towards the end (Filteau, 2007).  By undermining the goals of 
regenerative science, the propaganda confuses the reader and misinforms any opinion held. 
 Pope Benedict XVI has endorsed publically the use of stem cell research with regards to 
adult stem cells (Pope Benedict XVI, 2008).  The ethical quandary facing the possible 
destruction of human life with embryos to save another with regenerative medicine is overcome 
with adult stem cells derived from the patient themselves or cells induced into pluripotency.  The 
Catholic Church insists that scientific endeavors should never fail to respect human life at any 
stage of existence, and through the novel generation of stem cells this boundary is stepped over 
(Pope Benedict XVI, 2008). 
 Fr. Pacholczyk expresses the same sentiment of the Pope while also misconstruing 
experimental evidence in order to garner larger support for obstructing embryonic stem cell 
research. The statement of no cure yet reached by stem cell researchers (Smith, 2006) 
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misinforms readers, as multiple cases of humans regaining motor control after paralysis has been 
documented as discussed in Chapter-2. Partial regeneration of motor abilities should be enough 
to warrant any stem cell research. Should society trust the propaganda arm of the Catholic 
Church when they make statements which could harm the future of regenerative medicine? 
 
Christianity 
 The United Methodist Church has expressed a limited boundary on the use of embryonic 
stem cells. If the embryos are currently in excess from in-vitro clinics then they are of tolerable 
use (UMC, 2004). The use of excess embryonic stem cells allows progress of regenerative 
science. This modern science is required for advancing medical needs within communities. The 
Methodist Church requires that the embryos not be needed for procreation, that the donors give 
permission for scientific research use, and those embryos donated were not created solely for 
research purposes and were not obtained by sale or purchase (UMC, 2004). The United 
Methodist Church recognizes the need for progress in regenerative science in order to expand the 
ability to meet basic health needs of their own members, and does so by allowing controlled 
methods of donorship for research. 
 Reverend Fleischmann, writing from a conservative Christian perspective, poses a view 
similar to Catholic views on embryonic stem cell research. The embryo is given to humanity by 
god for procreation to occur.  Deriving embryonic stem cells confounds the purpose of that life 
form and is the murder of god (Fleischmann, 2001).  All life is of Christ, and any destruction of 
blastocysts murders the savior of humanity. The St. Stephen First Martyr Orthodox Church also 
expresses this viewpoint showing a rift between different sects within Christianity. The major 
argument is that life begins at conception, and no life is to be undone as this is a major sin 
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against god (Hodges, 2011). While the embryo is destroyed as a packet of cells, a counter 
argument that the cells themselves still survive should be succinct to void any Christian 
arguments.  Their state as a group of cells may have ended, but the individual stem cells are 
retained and grown into colonies of similar cells. These stem cells, while never reaching human 
form, can be fused with an existing human to help retain that human form. A question to pose for 
Christians is should a group of life forms acting together as a blastocyst never be broken into 
individual cells, while most of the original cells survive alone as cell lines? 
 Evangelist Christian writers within North America show a malformed perspective on 
stem cell research. They deny the existence of induced pluripotent stem cells, or even the 
existence of stem cells within an adult human body. This perspective forces the argument into 
their frame without any tolerance of juxtaposition. Stating that stem cell research only exists as 
embryonic research denies the existence of hematopoietic stem cells, neural progenitor cells and 
other adult stem cell research. This argument reaches many readers and sways their opinion of 
the research illegitimately (Cameron, 2005). 
 
Islam 
 In-vitro fertilization clinics are allowed under Islamic law as long as no surrogate mother 
is used, and the sperm of the father fertilizes the mother’s egg.  Excess fertilized embryos 
produced at these clinics not to be implanted into the mother can be used for stem cell research. 
According to Islam, the embryo is also considered as a potential life and not actual life, allowing 
for their harvesting and destruction if an overproduction occurs at the clinic (Siddiqi, 2002).  
Islamic law states an obligation to relieve human suffering and disease under fard kifayah.  In 
consideration of stem cell research, this obligation is met. Adult stem cells are to be prioritized 
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for research in contrast to embryonic stem cells when the possibility exists.  Embryos destined 
for destruction are allowed for stem cell harvest as they are potential lives not in their natural 
environment and have no possibility for generating an actual life (Siddiqi, 2002). 
 Shari’ah law within the Qur’an houses higher protection to actual life than potential life. 
The fertilized embryo is considered a potential life at the first forty days after conception, and 
within the next forty days any harm to that embryo is considered a potential homicide (Weckerly, 
2002).  Biotechnical intervention within the first forty days can be considered the ultimate will of 
god, and the research of improving human health an obligation towards knowledge. 
 
Judaism 
  The Jewish perspective on stem cell research involving embryos is lenient. From the first 
period of gestation to the 40
th
 day the embryo is considered holding the same rights as water. 
From the 41
st
 day and onward, the embryo is considered a part of the mother’s thigh 
metaphorically (Dorff, 2001).  Research on a thigh still attached to a human is generally un-
ethical, as would be research on the embryo which is now considered one with the mother 
regardless of the embryos location. Outside of this theological limit there are few confines to 
research for stem cells. Judaist practitioners base their views on Genesis 2:15, where all work 
done within the world is to preserve it due to divine duty (Dorff, 2001). By preserving human 
health via new clinical applications from research, the divine duty is fulfilled. One denial by 
Judaism of embryonic stem cell research is drugs that produce hyper-ovulation, as this can cause 
ovarian cancer and is a reversal of preservation (Dorff, 2001). 
 Within Jewish law the human life does not begin until the head of the child is more than 
halfway emerged from the mother’s body.  The soul of the human exists before birth but shall 
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always exist in consideration of human intervention (Rich, 1997). Two concepts related to the 
human body, where life does not begin until emergence, and that life must be preserved, shape 
the doctrine of embryonic harvesting.  Jewish ethicists adhering to pikuach nefesh, or the 
preservation of life, find the destruction of embryos for stem cell research a great benefit for 
human life (Yearwood, 2006). Traditional Jewish groups find some ethical concerns with the 
destruction of embryos due to the chance that they could develop into a human life, but this 
perspective is limited in scope. The vast majority of embryos used for research are not kept 
within the mother; most are left in stasis within a lab outside of any environment which may 
permit them to develop (Yearwood, 2006). Another argument made by traditional groups is that 
the embryo developing into a human life will benefit society. Contrary to this idea, how would a 
mother give birth to a thousand children during her lifetime? Not all blastocysts will mature into 
a human life. These non-developing cells can be used for the preservation of lives already in 
existence, fulfilling pikuach nefesh. 
 
iPS Ethics 
 Induced pluripotent stem cells maintain a neutral state within the moral spectrum due to 
the method of producing such cells. Small scrapings of skin can be converted into large colonies 
of stem cells, and while any clinical applications are still down the road, there is large promise of 
potential.  Ethical issues do arise when looking at long term outcomes of this technology. 
Healthcare costs could see dramatic reductions due to ubiquitous production of induced stem 
cells.  Embryo-derived stem cell lines might no longer be required as induced cells can be 
created from fibroblast skin cells taken from every living human, and can provide their own stem 
cell lines for expansion of the cells and for transplants.  
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As discussed in Chapter-1, whether these induced cells are truly pluripotent remains 
controversial.  Assuming they are eventually proven to be as potent as embryo-derived stem 
cells, mobile bio-reactors generating the stem cell colonies could take root within communities. 
Heavy injuries within combat environments could be overcome within weeks allowing greater 
fighting ability for the militaries of the world. Perhaps the regeneration rate could be altered 
within induced stem cells allowing quicker recovery times from injuries. Ethics of behavior 
might become more lenient due to ease of access medicine. Would societies become more 
complacent, or would greater risks become a norm?  
 
Chapter-3 Conclusions 
 The state of bio-technologies and regenerative medicine has gained large traction with the 
advent of new therapies for sick and suffering patients. War injuries, labor accidents, 
victimization within society, all are unjust acts committed on individuals. Morally, research and 
progress to help limit or end the suffering within society should be a prerogative of any group 
regardless of ideology.  Utilizing embryos until alternative solid and ethical methods are 
extrapolated might just be a sacrifice required to reduce the significant pain held by millions. 
Embryos gained with permission from reproductive clinics where their fate is destruction gives 
new meaning to the cellular packet of life.  Either these embryos can be destroyed with no 
purpose to humanity, or they can be expanded and implanted into humans in need giving some 
role to their existence.  Embryos gained for research purposes by non-fertilization donors does 
create an ethical quandary.  On one side, while the embryos would be utilized to pursue noble 
goals, their creation for sole purpose of destruction steps over the line of just behavior. However 
replenishment of the human population occurs through reproduction and limiting death rates.  If 
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death rates could be prevented through regenerative science, then perhaps the offset in 
reproductive behavior could be used ethically to help maintain human populations. 
 Adult human stem cells provide a retreat from the embryo ethical debate by only 
requiring materials from the patient or a donor’s own cells. These cells normally function to 
regenerate the human body; to catalyze this specialization through engineering may possibly be 
of higher ethical value than using embryonic stem cells. The consideration of harming the patient 
with foreign stem cells that might be rejected by their immune system is also side stepped using 
a patient’s own adult stem cells and allows greater healing. Mixing adult and induced pluripotent 
stem cells as a combined strategy in lieu of using embryo-derived stem cells increases the 
potential range of medical applications giving both types lasting power within the stem cell 
debate. 
 
Chapter-3 Bibliography 
American Catholic Organization (2006) “U.S. Bishops Protest Embryo Stem-cell Research”. 
http://www.americancatholic.org/News/StemCell/bishops_stemcell.asp 
 
Bahnot, Anil (2008) The Ethics of Stem Cell Research: A Hindu View. Bio News. 17 Oct. 2008. 
http://www.bionews.org.uk/page_38022.asp 
 
Cameron, Nigel (2005) The Stem-Cell Conspiracy. Christianity Today. 49(9). 
http://www.christianitytoday.com/ct/2005/septemberweb-only/12.0.html?start=2 
 
Dorff, Elliot (2001) "Embryonic Stem Cell Research: the Jewish Perspective." United Synagogue 
of Conservative Judaism. Dec. 2001. University of Judaism in Los Angeles. 
http://www.uscj.org/Embryonic_Stem_Cell_5809.html.  
 
Filteau J (2007) Stem-Cell Research and the Catholic Church.  American Catholic. 
http://www.americancatholic.org/News/StemCell/ 
 
Fleischmann, John (2001) “The Christian View on Embryonic Stem Cell Research: The 
Guidance of Holy Scripture” http://resqrev.com/Embryonicb.pdf 
 
34 
 
Hodges, Mark (2011) Destructive Embryonic Stem Cell Research. St. Stephen the First Martyr 
Orthodox Church. 
http://www.orthodoxresearchinstitute.org/articles/ethics/hodges_stem_cell_research.htm 
 
Hughes, James J., and Damien Keown (1995) "Buddhism and Medical Ethics: a Bibliographic 
Introduction."  Journal of Buddhust Ethics 2 (1995): 104-124.  
http://ftp.cac.psu.edu/pub/jbe/acrobat/hughes.pdf 
 
Pope Benedict XVI (2008) “Benedict endorses adult stem-cell research as respecting human 
life”. Catholic Online.  
http://www.catholic.org/international/international_story.php?id=21301 
 
Rich, Tracey R (1997) Birth and the First Month of Life.  Judaism 101. 1997.  
 http://www.jewfaq.org/birth.htm 
 
Siddiqi, Muzammil (2002) “An Islamic Perspective on Stem Cell Research.” IslamiCity.com. 27 
Feb. 2002.  http://www.islamicity.com/articles/Articles.asp?ref=IC0202-404 
 
Smith PJ (2006) Catholic Church NOT Opposed to Stem Cell Research.  Catholic Bioethicist. 
Retrieved Feb 12, 2008, from http://www.lifesite.net/ldn/2006/jul/06072709.html 
 
United Methodist Church (2004) Ethics of Embryonic Stem Cell Research.  
http://archives.umc.org/interior.asp?ptid=4&mid=6560 
 
Weckerly M (2002) The Islamic View on Stem Cell Research.  Rutgers Journal of Law and 
Religion.   http://org.law.rutgers.edu/publications/law-
religion/new_devs/RJLR_ND_56.pdf  
 
Yearwood PD (2006) Jewish Views on Stem Cell Research. MyJewishLearning.com database.  
http://www.myjewishlearning.com/ideas_belief/bioethics/Overview_Genetic_Issues/
Gene_Therapy_And_Genetic_Engineering/Bioethics_StemCell_CJN.htm 
 
 
  
35 
 
Chapter-4:  Stem Cell Legalities 
 
 
 The regulations on stem cell research constitute a high turnover system.  Over the past 
twenty years, regulations have moved from a tolerance ideology, to a hard line ban, switching 
back to a somewhat moderate stance most recently.  Allocated resources to support the research 
often end up withheld in red-tape. Even types of stem cell research deemed ethical face limits on 
funding due to ambiguous legislation. The National Institutes of Health ethical guidelines were 
ignored by the President and were halted in court.  Eventually, the court decision was overturned 
and new cell line approvals were made, but the strenuous flux of the law placed uncertainty on 
research goals (Ledford, 2011).  The funding flux caused even single cell extraction from the 
blastocyst to be halted, a non-destructive routine to allow genetic testing on an embryo. 
 
Early US Stem Cell and Embryo Policies 
The timeline of US legislation on stem cell research begins in the early 1960’s. In 1961 
the Foundation for Stem Cell Sciences was established by Dr James Till and Dr. Ernest 
McCulloch, creating the foundation for modern regenerative science.  During 1972, the decision 
from Roe v. Wade legalized some types of abortions, and in 1974 a ban on fetal research funding 
by federal sources was instituted to prevent the use of aborted tissue for research. During 1975, 
the Ethics Advisory Board was established in dealing with fetal research, but within five years it 
was dismantled by President Reagen. 1988 saw funding approval of embryo research, yet two 
years later President Bush Sr. vetoed a bill that would have lifted the ban on fetal research. 
During 1995, the US Congress enacted the Dickey-Wicker Amendment which banned all 
embryo research (Robertson, 2010).  This moratorium was ended by President Clinton until 
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President Bush Jr. reinstituted the ban. Not until 2009 under the Obama administration did the 
ban end, allowing state legislatures to create state-specific laws allocating resources and 
approving ethics guidelines (Stem Cell Tracker, 2009). 
 
Embryo and Stem Cell Legislation Under President Bush Jr. 
 With the first veto of President Bush’s two terms of service, a rejection of Congress’ 
decision to allow some types of embryo research was broached; Bush signaled a strong 
oppositional stance on the issue (Babington, 2006).  Bush’s main argument has parallels to 
Christian ethical stances on when life begins, and the Congressional vote was not sufficient to 
overturn the veto. Within the same week, President Bush signed a bill ending federal funding for 
the creation of new human embryos for organ harvesting. The nearly half million frozen embryos 
in North America were placed on disposal lists, as the couples donating only required a few for 
pregnancy (Babington, 2006).  The President stated that destroying an embryo is tantamount to 
murder.  Would voluntary abortions performed within the first few weeks of conception be 
treated as homicide as well?  The rationale behind the Bush policy was that destruction of an 
embryo constitutes murder. President Bush Jr. banned federal money to derive new embryonic 
cell lines yet allowed money to be spent on cell lines derived prior to 2001 as they had already 
been destroyed based on arguments he presented.    
 The policy of a hard line ban on novel research within regenerative sciences diminished 
North America’s stance from the forefront of modern medical care.  Some international 
communities devote stem cell lines and resources to global stem cell banks, where analysis of the 
stem cells deems whether they are worthy for research. These cells are then handed over to stem 
cell researchers under strict oversight (Cook, 2004). Expectantly over 100 new stem cell lines are 
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thought to be generated under this international system, while public researchers in North 
America barely retained nineteen cell lines under the Bush administration. Private researchers 
within North America have access to the international stem cell bank and are making large 
research progress.  During the Bush Jr. presidency, some investigators moved abroad to secure 
stable research labs not allowed under the influence of religious moralities (Cook, 2004). Young 
North American stem cell researchers also started moving abroad to escape the ban (Ford, 2002). 
In effect a brain drain developed as youth researchers immigrated to countries with stable bio-
research regulations. 
 Several groups such as the Howard Hughes Medical Institute and Advanced Cell 
Technology have invested capital and resources to private stem cell research initiatives (Holden, 
2006).  Start-up private groups, not bound by federal funding bans, are experiencing an increased 
leading role within society for the progressive science. One key obstacle is standardized practices 
within the research setting to ensure objective and significant experimental methods.  Without 
adopting the unified model that the National Institutes of Health proposes, sharing new insight 
and accomplishments requires learning each group’s unique methodologies. Another issue that 
creates obstruction to research is efficiency; many hours are lost in attempting to secure funding 
for the research under the ban, effectively hampering the time allotted each day for experimental 
goals (Ford, 2006; Holden, 2006). 
 
Embryo and Stem Cell Legislation Under President Obama 
 The ban under President Bush Jr. defied public opinion. With a two-to-one margin of 
support for funding stem cell research, including embryonic stem cell research, the ban was 
advocated only by a minority (Langer, 2005).  With a new president inaugurated in January of 
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2009, the public support of stem cell research reached the administration of President Obama and 
a reversal of the ban allowed significant resources to be instituted within public stem cell 
research organizations (CBS/AP, 2009).  Federal funds were allowed to create new lines of 
embryonic stem cells for use within North America, limited to embryos only obtained at 
reproductive clinics with donor consent and without pay, creating a competitive research 
foundation in contrast to the international community. The cited reasoning behind President 
Obama’s revocation of the ban parallels many world religious stances on the ending of human 
suffering through research discovery.  Another cited reason is to reverse the emigration of top 
scientists due to the ban (CBS/AP, 2009). 
As strict regulations were lifted, the National Institute of Health developed a 
comprehensive guideline for stem cell research and was met with optimism by scientists 
(Holden, 2009).   The new rules established by the NIH enable discretionary allowances of old 
stem cell lines and the creation of a registry for new stem cell lines. Ethical bans asserted under 
President Bush Jr. were replaced with committees staffed by scientists who maintain a case by 
case prognosis on whether each old stem cell line met ethical criteria (Holden, 2009). The 
registry, accessible to organizations doing stem cell research, vastly improves access to cell lines, 
and limits research done on unethical cell lines. One example of unethical behavior being 
imported lines derived from embryos with paid donors. The US legislative timeline closely 
parallels prohibition era reasoning; the ban caused economic, health and research deficits due the 
prohibitive state the nation resided upon.  By ending the ban and imposing reasonable 
regulations, the field of regenerative science could flourish while maintaining the sanctimony of 
ethics.  
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International Stem Cell Legislation 
 During the controversial Bush ban in the United States, British legislators held an  
opposing open view to the promise of stem cell research. The British stem cell bank was 
government financed and legislators had full support of embryonic stem cell research. 
Therapeutic cloning was licensed at the University of Newcastle giving researchers the ability to 
create embryonic clones for stem cell extraction (Rosenthal, 2004). Britain also allows paid 
donors to provide embryos, and enables research into somatic cell nuclear transfer technology.  
Internationally this gave Britain a leadership role in regenerative science. South Korean 
legislators also had high tolerance of stem cell research, promoting the World Stem Cell 
Foundation which envisioned around 100 new stem cell lines each year (Kaplan, 2005). These 
stem cell production lines were to be made available to world researchers, specifically private 
organizations within the United States during the ban. 
 Chinese progress within the stem cell field unifies Western and Eastern perspectives on 
the regenerative research. Religious and moral objections are scant within China’s cultural 
setting allowing greater flexibility for research (Barnes, 2006).  Outsourcing of research from 
Western nations to Chinese research groups allowed a bypassing of the United States ban.  One 
major cost of outsourcing was China’s well known weakness in protecting intellectual property 
rights for those Western organizations. The progress of regenerative science may outweigh the IP 
loss incurred by outsourcing companies however (Barnes, 2006).  
During the same year as the 2009 United States ban reversal, Japan instituted a relaxed 
regulation on stem cell research, allowing greater chances of novel discoveries (Cyranoski, 
2009).  Some countries across the world revoked religious moralities in hopes of grand progress 
within the field.   Germany lifted a blanket ban slightly by allowing foreign stem cell lines to be 
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imported before a cut-off date (Herman et al., 2008). Legislative bans placed on research, when 
such research is backed by popular opinion, cannot endure. Science finds a way to progress 
regardless of the climate, and to limit such progress removes that country from leadership 
positions.  
 The global perspective on stem cell research is linked by each country’s ideals. The 
lifting of the ban by President Obama allowed similar actions to be taken by some countries who 
view North America as a leading power within the world; however other countries based on their 
own religious and political views have instituted blanket bans on embryonic and stem cell 
research.  Countries that permit embryonic stem cell research or therapeutic cloning include 
Australia, Belgium, China, India, Israel, Japan, Singapore, South Korea, Sweden, and the United 
Kingdom.  Countries that do not permit therapeutic cloning but allow research on excess 
embryos created for reproduction include Brazil, Canada, France, Iran, South Africa, Spain, The 
Netherlands, Taiwan, and the USA.  Countries that outright prohibit human embryo research and 
permit limited research only on imported stem cell lines include Austria, Germany, Ireland, Italy, 
Norway and Poland. 
 
US State Specific Legislative Acts 
 In response to the Bush banning of federal funding supporting most types of embryonic 
stem cell research, several states passed legislations establishing their own private stem cell 
centers, while other states passed outright bans of the research.  California, Connecticut, Illinois, 
Maryland, Massachusetts, New Jersey and New York created legislation to fund embryonic stem 
cell research. Iowa, Michigan and Montana allowed the research but not with public funding. 
41 
 
North and South Dakota, Arkansas, Indiana and Louisiana outright banned any embryonic stem 
cell research (Vestal, 2009).   
New Jersey and California were the first to support stem cell research, with ten million 
and three billion, respectively, distributed over ten years. Massachusetts saw one billion 
allocated through grants during 2008 by Gov. Deval Patrick. Wisconsin invested 750 million in 
both public and private funding, and built a research facility specifically for embryonic stem cell 
research (Vestal, 2009). These states, also on the forefront of education, saw the promise of stem 
cells to regenerative science. The foresight of the politicians within these states allowed scientists 
to become community and world leaders for regenerative sciences. 
 Minnesota ethicists authoring a book titled “The Stem Cell Dilemma” are helping shape 
legislative action within that state. The authors, Dr. Leo Furcht and Dr. William Hoffman, 
indicate that a medical revolution is underway in the world (Schmickle, 2008).  Minnesota was 
caught between being a leader in stem cell science and respecting the moral ban instituted by 
President Bush Jr. and Sr.  Minnesota stands titled with the world’s first bone marrow transplant, 
utilizing stem cells from umbilical cords, and applying stem cells to scaffolds to create animal 
organs (Schmickle, 2008).  Such research was accomplished under the volatile legal system 
within the United States; with the ban lifted the limits of stem cell science and technology 
pioneering may indeed revolutionize biology. 
 Massachusetts has felt the effects of the volatile legislation prominently. Gov. Mitt 
Romney attempted a veto of a stem cell bill during the national ban, but was overturned by the 
state legislature. Scientists within the state only needed approval from a local district attorney in 
order to secure research rights (Daily News Central, 2005).  The bill did not include private 
funding leaving researchers stuck finding private sources of funding.  Two years later in 2007, 
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Gov. Deval Patrick allocated the one billion funding initiative for life science research (Marks, 
2007).  The funding specifically allocated funds to embryonic stem cell research centers 
propelling the state into a leadership role in regenerative sciences. The majority of funds were 
allocated to public research facilities including Worcester’s University of Massachusetts Medical 
School. While federal funds were banned from public use, state funds still had the flexibility to 
prop up research organizations within the public sphere. The state has allocated millions of 
dollars to create a Massachusetts Stem Cell Bank, touted to be the largest repository in the world 
(Marks, 2007).  Creating the stem cell bank gave Massachusetts international renown and helped 
secure the United States’ foothold.  Other allocations from the funding initiative created 
organizations to help increase translation of research innovations into marketable products.  One 
of the major blockades in novel research is the time taken to reach the public. This obstacle was 
addressed strategically by Gov. Deval Patrick and may pave the way for medical technologies to 
reach the sick quicker (Marks, 2007).  
 
Chapter-4 Conclusions 
 The influential nature of religion on legislation within different sects of the world can 
have tremendous effect on the potential limits science achieves. Leaders such as President Bush 
hinged their morality and ethics on minority constituents, while public opinion opposes such 
perspectives. Worldwide the legislative policies of various countries varies considerably from 
those allowing paid embryo donors and cloning, to countries outright banning all embryo 
research.  For most countries, the trend of stem cell research approaches tolerance and regulation 
by ethic committees. Rule-enforced stem cell banks have been created by the leaders of 
innovative regenerative technologies with resources unobtainable within other societies. Distinct 
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populations in each society force a bi-polar perspective on the stem cell laws. The United States 
shows prominent effects of this two state split. Every few years for several decades there have 
been moratoriums on embryonic stem cell research, bans and funding revocations. Progressive 
leaders in turn revert these science prohibitive enactments only to be met with yet another ban 
after their term ends.  European societies also face a similar conflict of interest where some 
populations such as Britain are mostly for the research, while others are held back ethically due 
to past transgressions such as Germany. Yet the trend towards open stem cell research is 
international and cannot be held back by secular populations in parts of the world.   
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Project Conclusions 
 
 Regenerative medicine is leading science into a revolution. Biology is being upturned 
with daily progressions in cellular research.  Philosophies regarding death from diseases are 
trending into philosophies of cell immortality and longer human lives.  Life, once thought to be 
hindered by organ failure, is undergoing drastic revisions. Stem cell applications make all of this 
possible. While many promises were made over the years, several positive advancements have 
recently stunned both the scientific community and the public. Limb regeneration, organ 
regeneration, even neural regeneration has begun to take root in clinical applications! The flex 
manipulation of the human body will inevitably lead to humans directing their bodies into doing 
what is required, reversing the role the body through aging or disease forces onto the mind.  
Before the advent of regenerative science, the mind reacted to the environment through the body. 
With the high paced progress in stem cell research, soon humans will dictate how their body will 
interact with the environment. Some humans might soon fail to resemble the sapiens form, others 
possibly perfecting the form. Of course only the future will know if such fiction exists. One 
certainty exists: the treatment of specific diseases with stem cells has already been successful, 
and will only continue to expand. 
 Controversy will continue to surround the use of embryonic stem cells. With adult stem 
cell research providing new applications for these less controversial cells, eventually the ES cell 
controversy may become past tense.  The frontier of human potential almost always becomes 
immersed in ethical debate and moral implications. The use of adult stem cells to treat diseases 
highlights a general turning point in the debate where controversy transforms into acceptance. 
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With research recently being achieved engineering entire synthetic genomes, perhaps one day 
stem cells can even be engineered without requiring the manipulation of existing cells.  
 The ramifications of stem cell technology are highly astounding.  Individuals once 
thought incurable now have hope of living normal lives. Men and women maimed by the horrors 
of war can now have hope of a brighter future without suffering. Some types of viral diseases 
originally believed to be incurable are approaching a state of being minor annoyances. Motor 
diseases, neural degeneration, muscle atrophy, sensory disabilities, every obstacle to normality is 
being broken down daily as regenerative science progresses. Yet that progress has only just 
begun, decades from now advancements will have been made possibly making current progress 
barely a footnote in the history of science.  The insurrection of the human body by the mind is 
just beginning.  Society must set the stage for a new wave of existence. 
 
